Electromed, Inc. (AMEX:ELMD) is reporting fourth quarter financial results on Tuesday 25th August 2020, after market close.
According to analysts surveyed by Thomson Reuters, ELMD is expected to report 4Q20 loss of $ 0.15 per share from revenue of $ 5.68 million.
For the full year, analysts anticipate top line of $ 31.27 million, while looking forward to income of $ 0.18 per share bottom line.
Stock Performance
Shares of Electromed, Inc. traded high $ 0.83 or 5.85 percent on Monday, reaching $ 15.03 with volume of 146.70 thousand shares. Electromed, Inc. has traded high as $ 15.58 and has cracked $ 14.26 on the downward trend
According to the previous trading day, closing price of $ 15.03, representing a 173.08 % increase from the 52 week low of $ 5.20 and a 28.03 % decrease over the 52 week high of $ 19.73.
The company has a market capital of $ 127.51 million and is part of the Healthcare sector and Medical Devices industry.
Conference Call
Electromed, Inc. will be hosting a conference call at 5:00 PM eastern time on 25th August 2020, to discuss its 4Q20 financial results with the investment community. The participants may dial, (877) 407-9753 Toll Free or (201) 493-6739 Outside U.S. in order to access the live audio call. A live webcast with presentations will be available on the Internet by visiting the Company website 78449.themediaframe.com/dataconf/productusers/elctr/mediaframe/40248/indexl.html
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality.
